Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Mirzaev K.B., Fedorinov D.S., Sychev D.A., Maksimova N.R., Chertovskih Ya.V., Popova Ya.V., Tayurskaya K.S., Rudykh Z.A.
Introduction. The aim of this study to determine carrier frequencies of polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease (CHD) patients in Russian and Yakut ethnic groups. The association between theadmin…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Temirbulatov I.I., Ivashchenko D.V., Rudykh Z.A., Popova N.V., Tayurskaya K.S., Chertovskikh Ya.V., Sychev D.A.
Introduction. Proton pump inhibitors (PPI) are widely spread as antisecretory drugs for a treatment of acid diseases, such as the gastric ulcer. Most of the proton pump inhibitors are inactivated in the liver by cytochromes P450 2C19 (CYP2C19) to the form of i…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Chertovskikh Ya.V., Shuev G.N., Popova N.V., Rudykh Z.A., Maksimova N. R., Grachev A.V., Sychev D. A.
Introduction. SLCO1B1 encodes the organic anion-transporting polypeptide which has been shown to regulate the hepatic uptake of statins. SLCO1B1*5 genetic variant is associated with the high risk for statin-induced myopathy in patients with statins therapy. Ai…